Ldl-receptor genotype dependent response to cholesterol-lowering therapy in patients with heterozygous familial hypercholesterolemia

被引：0
|
作者：
Kajinami, K [1 ]
Yagi, K [1 ]
Higashikata, T [1 ]
Inazu, A [1 ]
Koizumi, J [1 ]
Mabuchi, H [1 ]
机构：
[1] KANAZAWA UNIV,SCH MED,DEPT INTERNAL MED 2,KANAZAWA,ISHIKAWA 920,JAPAN
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88368-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [21] IMPROVEMENT OF ENDOTHELIUM-DEPENDENT CORONARY VASOMOTION BY CHOLESTEROL-LOWERING IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    SABATE, M
    CEQUIER, A
    PINTO, X
    ALIO, J
    GOMEZHOSPITAL, JA
    DELBLANCO, BG
    MAURI, J
    SALA, J
    SABATE, X
    ESPLUGAS, E
    CIRCULATION, 1995, 92 (08) : 186 - 186
  • [22] Ten-year follow-up of familial hypercholesterolemia patients after intensive cholesterol-lowering therapy
    Masaki, N
    Tatami, R
    Kumamoto, T
    Izawa, A
    Shimada, Y
    Takamatsu, T
    Katsushika, S
    Ishise, S
    Maruyama, Y
    Yoshimoto, N
    INTERNATIONAL HEART JOURNAL, 2005, 46 (05) : 833 - 843
  • [23] 4 NOVEL PARTIAL DELETIONS OF LDL-RECEPTOR GENE IN ITALIAN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    BERTOLINI, S
    GARUTI, R
    LELLI, W
    ROLLERI, M
    TIOZZO, RM
    GHISELLINI, M
    SIMONE, ML
    MASTURZO, P
    ELICIO, NC
    STEFANUTTI, C
    COVIELLO, D
    CARABBIO, C
    ORECCHINI, G
    CALANDRA, S
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (01) : 81 - 88
  • [24] Stimulation of LDL receptor expression by LDL-immuno-apheresis in patients with heterozygous familial hypercholesterolemia
    Streicher, J
    Valent, P
    Schmidt, H
    Sengolge, G
    Banyai, S
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 362 - 362
  • [25] A "de novo" mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia
    Pisciotta, L
    Cantafora, A
    De Stefano, F
    Langheim, S
    Calandra, S
    Bertolini, S
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (01): : 7 - 11
  • [26] CORRELATION BETWEEN LDL-RECEPTOR ACTIVITY IN FIBROBLASTS AND REDUCTION OF PLASMA LDL CHOLESTEROL DURING TREATMENT WITH SIMVASTATIN IN FAMILIAL AND NON-FAMILIAL HYPERCHOLESTEROLEMIA
    WALLI, AK
    THIERY, J
    CREUTZFELDT, C
    CREUTZFELDT, W
    ARTERIOSCLEROSIS, 1988, 8 (05): : A565 - A565
  • [27] Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia
    Day, INM
    Whittall, RA
    ODell, SD
    Haddad, L
    Bolla, MK
    Gudnason, V
    Humphries, SE
    HUMAN MUTATION, 1997, 10 (02) : 116 - 127
  • [28] Familial Hypercholesterolemia Patients with COVID-19-Effective Cholesterol-Lowering Therapy is Urgent both during and after Infection
    Vuorio, Alpo
    Raal, Frederick
    Kovanen, Petri T.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (12)
  • [29] A LARGE DELETION OF LDL-RECEPTOR GENE IN 3 UNRELATED ITALIAN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)
    LELLI, N
    GHISELLINI, M
    COVIELLO, DA
    MASTURZO, P
    BERTOLINI, S
    CALANDRA, S
    ARTERIOSCLEROSIS, 1990, 10 (05): : A800 - A800
  • [30] Influence of aging on serum cholesterol levels in heterozygous familial hypercholesterolemia patients with long-term LDL apheresis therapy
    Miwa, K
    Toudou, Y
    Kawashiri, M
    Higashikata, T
    Inazu, A
    Koizumi, J
    Mabuchi, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 173 - 173
12345